Hypoglycaemia in Clinical Diabetes

138 COUNTERREGULATORY DEFICIENCIES IN DIABETESDavis SN, Fowler F, Costa S (2000b). Hypoglycemic counterregulatory responses differ between menand women with type 1 diabetes. Diabetes 49: 65–72.Debrah K, Sherwin RS, Murphy J, Kerr D (1996). Effect of caffeine on recognition of and physiologicalresponses to hypoglycaemia in insulin-dependent diabetes. Lancet 347: 19–24Diem P, Redmon JB, Abid M, Moran A, Sutherland DE, Halter JB, Robertson RP (1990). Glucagon,catecholamine and pancreatic polypeptide secretion in type I diabetic recipients of pancreas allografts.Journal of Clinical Investigation 86: 2008–13.Fisher M, Frier BM (1993). Hypoglycaemia and human insulin. In: Hypoglycaemia and Diabetes:Clinical and Physiological Aspects. Frier BM and Fisher M, eds. Edward Arnold, London: 314–27.Fisher S, Brunning J, Lannon S, Kahn CR (2005). Insulin signaling in the central nervous system iscritical for the normal sympathoadrenal response to hypoglycemia. Diabetes 54: 1447–51.Flanagan D, Kerr D (1996). Recurrent hypoglycemia and long-standing brittle diabetes. Endocrinologyand Metabolism 3: 67–69.Frier BM, Fisher M, Gray CE, Beastall GH (1988). Counterregulatory hormonal responses to hypoglycaemiain type 1 (insulin-dependent) diabetes: evidence for diminished hypothalamic-pituitaryhormonal secretion. Diabetologia 31: 421–9.Gabriely I, Shamoon H (2005). Fructose normalizes specific counterregulatory responses to hypoglycemiain patients with type 1 diabetes. Diabetes 54: 609–16.Gerich JE, Langlois M, Noacco C, Karam JH, Forsham PH (1973). Lack of glucagon response tohypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect. Science 182: 171–3.Gerich JE, Bolli GB (1993). Counterregulatory failure. In: Hypoglycaemia and Diabetes: Clinical andPhysiological Aspects. Frier BM and Fisher M, eds. Edward Arnold, London: 253–67.Guldstrand M, Ahren B, Wredling R, Backman L, Lins P, Adamson U (2003). Alteration of thecounterregulatory responses to insulin-induced hypoglycemia and of cognitive function after massiveweight reduction in severely obese subjects. Metabolism 52: 900–7.Hardy KJ, Burge MR, Boyle P, Scarpello JHB (1994). A treatable cause of recurrent severe hypoglycemia.Diabetes Care 17: 722–4.Heine RJ, Van der Heyden EAP, Van der Veen EA (1989). Responses to human and porcine insulinin healthy subjects. Lancet 334: 946–9.Heller SR, Cryer PE (1991). Reduced neuroendocrine and symptomatic responses to subsequenthypoglycemia after 1 episode of hypoglycemia in non-diabetic humans. Diabetes 40: 223–6.Hvidberg A, Juel Christensen N, Hilsted J (1998). Counterregulatory hormones in insulin-treateddiabetic patients admitted to an Accident and Emergency Department with hypoglycaemia. DiabeticMedicine 15: 199–204.Jacqueminet S, Masseboeuff N, Rolland M, Grimaldi A, Sachon C (2005). Limitations of the so-called‘intensified’ insulin therapy in type 1 diabetes mellitus. Diabetes Metabolism 31(4 Pt 2): 4S45–50.Jones TW, Boulware SD, Kraemer DT, Caprio S, Sherwin RS, Tamborlane WV (1991). Independenteffects of youth and poor diabetes control on responses to hypoglycemia in children. Diabetes 40:358–63.Jones TW, Porter P, Sherwin RS, Davis EA, O’Leary P, Frazer F et al. (1998). Decreased epinephrineresponses to hypoglycemia during sleep. New England Journal of Medicine 338: 1657–62.Jorgensen L, Dejgaard A, Pramming SK (1994). Human insulin and hypoglycaemia: a literature survey.Diabetic Medicine 11: 925–34.Kerr D, Reza M, Smith N, Leatherdale BA (1991). Importance of insulin in subjective, cognitive andhormonal responses to hypoglycemia in patients with IDDM. Diabetes 40: 1057–62.Kerr D, Tamborlane WV, Rife F, Sherwin RS (1993). Effect of insulin-like growth factor-1 on theresponses to and recognition of hypoglycemia in humans. Journal of Clinical Investigation 91:141–7.Kumagai AK, Kang YS, Boado RJ, Pardridge WM (1995). Upregulation of blood-brain barrier GLUT-1 glucose transporter protein and mRNA in experimental chronic hypoglycemia. Diabetes 44:1399–404.